Search Results 1-10 of 18777 for intestinal metaplasia

  1. Examining the impact of endoscopic resection approach on intestinal metaplasia and dysplasia recurrence after complete remission: EMR versus ESD - Mayo Clinic

    Mayo Clinic researchers have previously demonstrated that both ER approaches yield comparable rates of complete remission of intestinal metaplasia (CRIM).

  2. Gastrointestinal Neoplasia Clinic - Overview

    Gastrointestinal stromal tumors (GISTs); Gastric intestinal metaplasia; Lymphoma of colon or rectum; Melanoma of the GI tract; Uncommon neoplasms of the stomach ...

  3. Digestive Diseases News - Medical Professionals - Mayo Clinic

    Examining the impact of endoscopic resection approach on intestinal metaplasia and dysplasia recurrence after complete remission: EMR versus ESD. Endoscopic ...

  4. A Study Of Obstructive Sleep Apnea On Barrett’s Esophagus Treatment Outcomes - Mayo Clinic

    ... intestinal metaplasia (CRIM). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or ...

  5. Barrett's Esophagus Clinical Trials - Mayo Clinic Research

    This study is designed to evaluate the effect of dexlansoprazole QD and BID dosing on the recurrence of intestinal metaplasia (IM) in subjects who achieved ...

  6. GI Cancer Clinic - Mayo Clinic Healthcare

    Known or suspected gastrointestinal cancers, such as stomach, small bowel, colon or rectal cancer. ... Gastric intestinal metaplasia. Lymphoma of colon or rectum.

  7. Barrett's Esophagus Clinical Trials - Mayo Clinic Research

    This study is designed to evaluate the effect of dexlansoprazole QD and BID dosing on the recurrence of intestinal metaplasia (IM) in subjects who achieved ...

  8. Barrett's Esophagus Clinical Trials

    This study is designed to evaluate the effect of dexlansoprazole QD and BID dosing on the recurrence of intestinal metaplasia (IM) in subjects who achieved ...

  9. Does Intensive Acid Suppression Reduce Esophageal Inflammation and Recurrent Barrett's Esophagus Following Ablation? - Mayo Clinic

    ... intestinal metaplasia following endoscopic ablation. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and ...

  10. Effect of Dexlansoprazole 60 mg QD and 60 mg BID on Recurrence of Intestinal Metaplasia in Subjects Who Have Achieved Complete Eradication of Barrett's Esophagus with Radiofrequency Ablation - Mayo Clinic

    This study is designed to evaluate the effect of dexlansoprazole QD and BID dosing on the recurrence of intestinal metaplasia (IM) in subjects who achieved ...